Tiempo real estimado
Otros sitios de cotización
|
Varia. Cinco días. | Varia. 1 de enero. | ||
0,53 USD | -2,54 % | +5,47 % | -2,36 % |
Resumen de negocios
Número de empleados: 405
Ventas por actividad
USD en millones | 2022 | Peso | 2023 | Peso | Delta |
---|---|---|---|---|---|
Zinc Finger Protein
100,0
%
| 111 | 100,0 % | 176 | 100,0 % | +58,34 % |
Ventas por región
USD en millones | 2022 | Peso | 2023 | Peso | Delta |
---|---|---|---|---|---|
United States
100,0
%
| 111 | 100,0 % | 176 | 100,0 % | +58,34 % |
Directores
Directores | Puesto | Edad | Desde |
---|---|---|---|
Alexander Macrae
CEO | Chief Executive Officer | 61 | 01/06/16 |
Director of Finance/CFO | 46 | 01/03/19 | |
Gregory Davis
CTO | Chief Tech/Sci/R&D Officer | - | 01/05/20 |
Phillip Ramsey
CTO | Chief Tech/Sci/R&D Officer | - | - |
Louise Wilkie
IRC | Investor Relations Contact | - | 01/09/20 |
Amy Pooler
PRN | Corporate Officer/Principal | - | - |
Corporate Officer/Principal | - | 01/09/19 | |
Scott Willoughby
LAW | General Counsel | - | - |
Administradores
Administradores | Puesto | Edad | Desde |
---|---|---|---|
Peg Horn
BRD | Director/Board Member | 61 | 15/12/22 |
James Meyers
BRD | Director/Board Member | 58 | 22/11/19 |
H. Parker
CHM | Chairman | 68 | 19/06/14 |
Kenneth Hillan
BRD | Director/Board Member | 63 | 11/09/20 |
Robert Carey
BRD | Director/Board Member | 65 | 01/06/16 |
Karen Smith
BRD | Director/Board Member | 56 | 28/06/18 |
Alexander Macrae
CEO | Chief Executive Officer | 61 | 01/06/16 |
John Markels
BRD | Director/Board Member | 58 | 11/02/20 |
Courtney Beers
BRD | Director/Board Member | 54 | 15/12/22 |
Clase de acciones
Vote | Quantity | Flotante | Autocontrol | Total Float | |
---|---|---|---|---|---|
Acción A | 1 | 207 495 609 | 191 497 330 ( 92,29 %) | 0 | 92,29 % |
Información de la empresa
Sector
Revisiones del BPA
Varia. 1 de ene. | Capi. | |
---|---|---|
-2,36 % | 113 M | |
-1,41 % | 104 mil M | |
+7,28 % | 97,47 mil M | |
+5,71 % | 22,25 mil M | |
-12,88 % | 21,68 mil M | |
-9,70 % | 18,2 mil M | |
-39,98 % | 17,02 mil M | |
-9,72 % | 16,36 mil M | |
+8,47 % | 14,39 mil M | |
+39,18 % | 12,37 mil M |
- Bolsa de valores
- Acciones
- Acción SGMO
- Empresa Sangamo Therapeutics, Inc.